Decreased Progesterone Receptor B/A Ratio in Endometrial Cells by Tumor Necrosis Factor-Alpha and Peritoneal Fluid from Patients with Endometriosis

다국어 초록 (Multilingual Abstract)

Purpose: Progesterone resistance is thought to be a major factor that contributes to progression of endometriosis. However, it is not clear what causes progesterone resistance in endometriosis. This study aimed to assess whether cytokines or peritoneal fluid can affect progesterone receptor (PR) expression in endometrial cells and to verify whether PR expression is reduced in endometriosis.
Materials and Methods: The PR-B/A ratio was measured via real-time polymerase chain reaction after in vitro culture, in which endometrialcells were treated with either tumor necrosis factor-alpha (TNF-α), interleukin-1 beta, or peritoneal fluid obtained from women with advanced-stage endometriosis. Immunohistochemistry was performed to compare PR-B expression between eutopic and ectopic endometrial tissues from women with and without advanced-stage endometriosis.
Results: The PR-B/A ratio was significantly decreased by treatment with either TNF-α (p=0.011) or peritoneal fluid from women with advanced-stage endometriosis (p=0.027). Immunoreactivity of PR-B expression was significantly lower during the secretory phase than during the proliferative phase in endometrial tissues from control subjects (p<0.001). PR-B expression was significantlyreduced in the eutopic endometrium (p=0.031) and ovarian endometrioma (p=0.036) from women with advanced-stage endometriosis compared with eutopic endometrium tissues from control subjects.
Conclusion: Progesterone resistance in endometriosis may be caused by proinflammatory conditions in the pelvic peritoneal microenvironment.

참고문헌 (Reference)

1 Hayashi A, "Yamashita Y, et al. Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis" 5 : 31-, 2012

2 김성훈, "Update on the treatment of endometriosis" 대한생식의학회 40 (40): 55-59, 2013

3 Lee MY, "Up-regulation of p21-activated kinase 1 by in vitro treatment with interleukin 1-beta and its increased expression in ovarian endometriotic cysts" 96 : 508-511, 2011

4 Eisermann J, "Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery" 50 : 573-579, 1988

5 Chen DB, "Stimulation of prostaglandin (PG) F2 alpha and PGE2 release by tumour necrosis factor-alpha and interleukin-1 alpha in cultured human luteal phase endometrial cells" 10 : 2773-2780, 1995

6 "Revised American Society for Reproductive Medicine classification of endometriosis: 1996" 67 : 817-821, 1997

7 Kim SH, "Regulation of P21-activated kinase-4 by progesterone and tumor necrosis factor-α in human endometrium and its increased expression in advanced-stage endometriosis" 98 : E238-E248, 2013

8 Osteen KG, "Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis" 83 : 529-537, 2005

9 Bulun SE, "Progesterone resistance in endometriosis: link to failure to metabolize estradiol" 248 : 94-103, 2006

10 Attia GR, "Progesterone receptor isoform A but not B is expressed in endometriosis" 85 : 2897-2902, 2000

11 Mori H, "Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease" 26 : 62-67, 1991

12 Hill JA, "Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis" 161 : 861-864, 1989

13 Fakih H, "Interleukin-1: a possible role in the infertility associated with endometriosis" 47 : 213-217, 1987

14 Lee II, "Influence of AKT on progesterone action in endometrial diseases" 91 : 63-, 2014

15 Lessey BA, "Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy" 51 : 409-415, 1989

16 Kao LC, "Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility" 144 : 2870-2881, 2003

17 Eskenazi B, "Epidemiology of endometriosis" 24 : 235-258, 1997

18 Giudice LC, "Endometriosis" 364 : 1789-1799, 2004

19 Kim SH, "Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis" 24 : 1133-1141, 2009

20 Misao R, "Dominant expression of progesterone receptor form B mRNA in ovarian endometriosis" 52 : 30-34, 1999

21 Noyes RW, "Dating the endometrial biopsy" 122 : 262-263, 1975